Ministry of Education
Preet Mohinder Singh Bedi
VIDWAN ID: 55211

Prof Preet Mohinder Singh Bedi

Male Doctor of Philosophy
Professor | Department of Pharmaceutical Sciences
Guru Nanak Dev University College, Verka
Punjab
Expertise: Pharmacology and Pharmacy
Scopus 6701896907
View older version My Dashboard
30 Publications
0 Projects
265 Scopus Citations
247 CrossRef
29 Years Total Experience
Publications
30 Total
Articles
29
Chapters
1
Activity

No publication activity to display.

Scopus Scopus
265 Citations
10 h-index
CrossRef CrossRef
247 Citations
10 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Personal Details

Doctor of Philosophy
N/A
Professor
Sep 1997 – Present
Guru Nanak Dev University College, Verka | Department of Pharmaceutical Sciences
Medical and Health Sciences
Pharmacology and Pharmacy

Related Profiles

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFRwt and mutant EGFRT790M receptor tyrosine kinases

Journal Article
Journal of Biomolecular Structure and Dynamics. Year: 2024. Volume: 42 , Issue: 23 , Pages: 13130-13152 .
Authors: Altaf Ahmad Shah; Nitish Kumar; Preet Mohinder Singh Bedi; Salman Akhtar
DOI 10.1080/07391102.2023.2274974 Crossref Crossref: 4 Scopus Scopus: 3

Discovery of triazole tethered thymol/carvacrol-coumarin hybrids as new class of α-glucosidase inhibitors with potent in vivo antihyperglycemic activities

Journal Article
European Journal of Medicinal Chemistry. Year: 2024. Volume: 263 .
Authors: Atamjit Singh; Karanvir Singh; Kirandeep Kaur; Aman Sharma; Pallvi Mohana; Jignesh Prajapati; Uttam Kaur; Dweipayan Goswami; Saroj Arora; Renu Chadha; Preet Mohinder Singh Bedi
DOI 10.1016/j.ejmech.2023.115948 Crossref Crossref: 34 Scopus Scopus: 38

Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes

Review
Journal of Molecular Structure. Year: 2024. Volume: 1295 .
Authors: Atamjit Singh; Karanvir Singh; Aman Sharma; Jasleen Kaur; Ramanpreet Kaur; Jashandeep Kaur; Kirandeep Kaur; Renu Chadha; Preet Mohinder Singh Bedi
DOI 10.1016/j.molstruc.2023.136557 Crossref Crossref: 22 Scopus Scopus: 25

Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023)

Review
Bioorganic Chemistry. Year: 2024. Volume: 143 .
Authors: Nitish Kumar; Komalpreet Kaur; Navjot Kaur; Ekampreet Singh; Preet Mohinder Singh Bedi
DOI 10.1016/j.bioorg.2023.107042 Crossref Crossref: 18 Scopus Scopus: 18

Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies

Review
ARCHIV DER PHARMAZIE. Year: 2024. Volume: 357 , Issue: 4 .
Authors: Harmandeep Kaur Gulati; Aanchal Khanna; Nitish Kumar; Anchal Sharma; Rupali; Jyoti; Jatindervir Singh; Kavita Bhagat; Preet Mohinder Singh Bedi
DOI 10.1002/ardp.202300296 Crossref Crossref: 8 Scopus Scopus: 8

Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents

Review
Molecular and Cellular Biochemistry. Year: 2024. Volume: 479 , Issue: 5 , Pages: 1165-1198 .
Authors: Atamjit Singh; Karanvir Singh; Aman Sharma; Sambhav Sharma; Kevin Batra; Kaustubh Joshi; Brahmjeet Singh; Kirandeep Kaur; Renu Chadha; Preet Mohinder Singh Bedi
DOI 10.1007/s11010-023-04786-0 Crossref Crossref: 6 Scopus Scopus: 9

Recent developments in synthetic strategies and pharmacological outcomes of synthetic xanthine oxidase inhibitors: A comprehensive review

Review
JOURNAL OF HETEROCYCLIC CHEMISTRY. Year: 2024. Volume: 61 , Issue: 5 , Pages: 723-752 .
Authors: Gurinder Kaur; Rajiv Sharma; Ashu; Geetakshi Arora; Atamjit Singh; Preet Mohinder Singh Bedi; Kundan Singh Bora
DOI 10.1002/jhet.4796 Crossref Crossref: 5 Scopus Scopus: 6

Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships

Open Access
Review
Biomedicines. Year: 2024. Volume: 12 , Issue: 6 .
Authors: Atamjit Singh; Karanvir Singh; Kamaljit Kaur; Amandeep Singh; Aman Sharma; Kirandeep Kaur; Jaskirat Kaur; Gurleen Kaur; Uttam Kaur; Harsimran Kaur; Prabhsimran Singh; Preet Mohinder Singh Bedi
DOI 10.3390/biomedicines12061192 Crossref Crossref: 17 Scopus Scopus: 18
Showing 1 to 8 of 30 publications